A randomized phase ii trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer

Oncology (Switzerland)

Volumn 54, Issue 5, 1997, Pages 438-439

  Colleoni, M ^a   Manente, P ^a   Stocker, J ^b   Amor, H ^b   Lamon, S ^a   Nelli, P ^a   Vicario, G ^a   Sgarbossa, G ^a   Graiff, C ^b  

^a Division of Medical Oncology   (Italy)

^b Medical Oncology Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; NAVELBINE;

ADULT; AGED; BONE MARROW TOXICITY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; LETTER; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; MITOMYCIN; TREATMENT OUTCOME; VINBLASTINE;

EID: 0030761987     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227731     Document Type: Article

References (8)

1. Fumoleau P, Delgado FM, Delozier T: Phase II trial of weekly intravenous vinorelbine in first line advanced breast cancer chemotherapy. J Clin Oncol 1993;11:1245-1252.
2. Romero A, Rabinovich MG, Vallejo CY; Vinorelbine as first line chemotherapy for metastatic breast carcinoma. J Clin Oncol 1994; 12: 336-341.
3. Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, Santi L: Phase II study of navelbine in advanced breast cancer. Semin Oncol 1989;16:33-36.
4. Frank W, Osteber AE: Mitomycin C: An evaluation of the Japanese report. Cancer Chemo-therRep 1960;1:114-117.
5. Brambilla C, Zambetti M, Ferrari L, Bonadon-na G: Mitomycin-C and vinblastine in advanced refractory breast cancer. Tumori 1980; 75:141-144.
6. Degardin M, Bonneterre J, Hecquet B, Pion JM, Adcnis A: Vinorelbine (navelbine) as salvage treatment for advanced breast cancer. Ann Oncol 1994;5:423-426.
7. Besenval M, Delgado M, Demarez JP, Kriko-rian A: Safety and tolerance of navelbine in phase I-II clinical studies. Semin Oncol 1989; 16:37-40.
8. Sceithauer W, Komek G, Haider K, Kwansy W, Shenk T: Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin-c. Breast Cancer Res Treat 1993;26:49-53.